Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 31;20(1):2372883.
doi: 10.1080/21645515.2024.2372883. Epub 2024 Jul 8.

Parental willingness to pay and preference for human papillomavirus vaccine for girls aged 9-14 in subsidy scenarios in Shanghai, China

Affiliations

Parental willingness to pay and preference for human papillomavirus vaccine for girls aged 9-14 in subsidy scenarios in Shanghai, China

Weiyu Zhou et al. Hum Vaccin Immunother. .

Abstract

Multiple studies have documented low human papillomavirus (HPV) vaccine uptake among Chinese girls. It remains crucial to determine the parental willingness to pay (WTP) HPV vaccine for girls. We conducted a cross-sectional study recruiting 3904 parents with girls aged 9-14 in Shanghai, China, employing an online questionnaire with a convenience sampling strategy. Parental WTP, both range of payment and estimated point value, were determined for themselves (or wives) and daughters. HPV vaccine uptake was 22.44% in mothers and 3.21% in daughters. Respondents favored WTP ≤ 1000 CNY/138 USD for themselves (or wives), whereas showed increasing WTP along with valency of HPV vaccine for daughters (2-valent: 68.62% ≤1000 CNY/138 USD; 4-valent: 56.27% 1001-2000 CNY/138-277 USD; 9-valent: 65.37% ≥2001 CNY/277 USD). Overall, respondents showed higher WTP for daughters (median 2000 CNY/277 USD; IQR 1000-3600 CNY/138-498 USD) than for themselves (2000 CNY/277 USD; 1000-3500 CNY/138-483 USD) or wives (2000 CNY/277 USD; 800-3000 CNY/110-414 USD) (each p < .05). Furthermore, parental WTP was higher for international vaccine and 9-valent vaccine (each p < 0.05). Between two assumed government subsidy scenarios, parental preference for 9-valent vaccine remained consistently high for daughters (approximately 24% in each scenario), whereas preference for themselves (or wives) was sensitive to payment change between the subsidy scenarios. Using a discrete choice experiment, we found domestic vaccine was commonly preferred; however, certain sociodemographic groups preferred multivalent HPV vaccines. In conclusion, the valency of HPV vaccine may influence parental decision-making for daughters, in addition to vaccine price. Our findings would facilitate tailoring the HPV immunization program in China.

Keywords: China; girl; human papillomavirus vaccine; preference; vaccine intent; willingness to pay.

PubMed Disclaimer

Conflict of interest statement

YL received the grant from MSD China for research in modeling and health economics of HPV vaccination in adolescent girls, and also kinetics of immune response to COVID-19 infection after recovery.

Figures

Figure 1.
Figure 1.
Human papillomavirus (HPV) vaccination status among mothers (respondents themselves or their wives) and daughters. “Had been vaccinated/had made an appointment” indicated the HPV vaccine uptake. “Intended to accept HPV vaccination, while had not made an appointment” indicated the intent to accept HPV vaccine; the intent was expressed by the respondents for themselves (or their wives) and for their daughters. “Did not intend to receive HPV vaccination” indicated no intent.

Similar articles

Cited by

References

    1. Zhang W XX, W SY, Zhang ZN, Yu WZ, Yu WZ.. Expert recommendations on human papillomavirus vaccine immunization strategies in China. Zhonghua Yu Fang Yi Xue Za Zhi. [2022 Sep 6]. 56(9):1165–10. Chinese. doi: 10.3760/cma.j.cn112150-20220505-00443. - DOI - PubMed
    1. Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. [2019 Aug 16]. 68(32):698–702. doi:10.15585/mmwr.mm6832a3. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention. HPV Vaccine Safety . 2021. [accessed 2023 Oct 10]. https://www.cdc.gov/hpv/hcp/vaccine-safety-data.html;.
    1. Villa A, Patton LL, Giuliano AR, Estrich CG, Pahlke SC, O’Brien KK, Lipman RD, Araujo MWB. Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines: umbrella review of systematic reviews. J Am Dent Assoc. 2020. Apr. 151(4):245–54.e24. doi:10.1016/j.adaj.2019.10.010. - DOI - PubMed
    1. Pan X, Lv H, Chen F, Wang Y, Liang H, Shen L, Chen Y, Hu Y. Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system. Hum Vaccines Immunother. 2021;17(10):3823–30. doi:10.1080/21645515.2021.1939621. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources